BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2681741)

  • 1. Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in women.
    Spitz IM; Shoupe D; Sitruk-Ware R; Mishell DR
    J Reprod Fertil Suppl; 1989; 37():253-60. PubMed ID: 2681741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined use of prostaglandin and antiprogestin in human fertility control.
    Baulieu EE
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():55-62. PubMed ID: 7732905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of RU 486.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteal phase contraception with mifepristone (RU 486) in the rhesus monkey.
    Ghosh D; De P; Sengupta J
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):17-22. PubMed ID: 8132238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiprogesterones.
    Norman J
    Br J Hosp Med; 1991 Jun; 45(6):372-5. PubMed ID: 2070168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mifepristone on inhibition of ovulation and induction of luteolysis.
    Spitz IM; Croxatto HB; Lähteenmäki P; Heikinheimo O; Bardin CW
    Hum Reprod; 1994 Jun; 9 Suppl 1():69-76. PubMed ID: 7962472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RU 486: an overview of mifepristone and its potential applications.
    Contracept Rep; 1993 May; 4(2):7-9. PubMed ID: 12286473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical use of RU 486 (Mefipristone).
    Herrmann W
    Res Reprod; 1989 Oct; 21(4):3. PubMed ID: 12282921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RU 486 (mifepristone): from clinical trials to the perspectives for clinical use.
    Elia D; Ulmann A
    Contracept Fertil Sex (Paris); 1986 Dec; 14(12):1099-103. PubMed ID: 12314688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward developing a once-a-month pill: a double-blind, randomized, controlled trial of the effect of three single doses of mifepristone given at midcycle on the pattern of menstrual bleeding.
    Narvekar N; Glasier A; Dada K; Van der Spuy Z; Ho PC; Cheng L; Baird DT
    Fertil Steril; 2006 Oct; 86(4):819-24. PubMed ID: 17027354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
    Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
    Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contranidatory activity of early luteal phase administration of mifepristone in the rhesus monkey.
    Ghosh D; De P; Sengupta J
    Indian J Physiol Pharmacol; 1993 Jan; 37(1):13-8. PubMed ID: 8449539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolysis in humans and subhuman primates.
    Henzl MR
    Res Prostaglandins; 1972 May; 1(5):1-3. PubMed ID: 12337004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of anti-progesterones as a medical IUD.
    Nieman LK; Loriaux DL
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraceptive potential of RU 486 by ovulation inhibition: III. Preliminary observations on once weekly oral administration.
    Danforth DR; Dubois C; Ulmann A; Baulieu EE; Hodgen GD
    Contraception; 1989 Aug; 40(2):195-200. PubMed ID: 2503298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One day estrous cycle shortening induced by antiprogestagen RU486 administration in proestrus to 4-day cyclic rats.
    Tébar M; Ruiz A; Sánchez-Criado JE
    Rev Esp Fisiol; 1995 Jun; 51(2):85-91. PubMed ID: 8532955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new antiprogestational compound, mifepristone (RU-486)].
    Parisi C; Steffe M
    Patol Clin Ostet Ginecol; 1988; 16(4):291-4. PubMed ID: 12345008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual regulation by mifepristone plus prostaglandin: results from a multicentre trial. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation.
    Hum Reprod; 1995 Feb; 10(2):308-14. PubMed ID: 7769054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contragestion with late luteal administration of RU 486 (Mifepristone).
    Dubois C; Ulmann A; Baulieu EE
    Fertil Steril; 1988 Oct; 50(4):593-6. PubMed ID: 3049166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.